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Most countries in Western Europe 
are currently free of rabies in 
terrestrial mammals. Nevertheless, 
rabies remains a residual risk to 
public health due to the natural 
circulation of European bat 
lyssaviruses (EBLV-1 & EBLV-2), 
which are widely distributed 
throughout Europe. Little is known 
of their true prevalence and 
epidemiology. In Switzerland, a 
total of 837 bat brain specimens 
have been analysed in FAT 
(fluorescent antibody test)/RTCIT 
(rabies tissue-culture infection test) 
between 1976 and 2009. 
Daubenton's bat was the only 
species found to be positive, one in 
August 24, 1992 in Plaffeien, canton 
of Fribourg, one in July 10, 1993 in 
Versoix, canton of Geneva and one 
in September 2, 2002 in the City of 
Geneva, canton of Geneva. So far, 
no bat infected with EBLV-1 has 
been found. The numbers of bats 
submitted varied from 1 to several 
dozens since 1986. Almost 50% of 
the submitted specimens were 
pipistrelles (Pipistrellus spp.) 
whereas only 64 bats were M. 
daubentoni (7.6%), and 21 were 
Eptesicus serotinus (2.5 %), the two 
main vectors of EBLVs. Overall, the 
area covered roughly the most 
suitable habitats for bats in 
Switzerland, avoiding higher 
mountainous regions. 
 
A total of 237 bats captured at 
different sites in western 
Switzerland in 2009, including 148 
M. daubentoni, 51 M. myotis, 23 E. 
serotinus and 15 N. noctula were 
analysed for both viral RNA and 
antiviral neutralising antibodies 
(RFFIT, rapid fluorescent focus 
inhibition test, Smith et al., 1973; 
Zalan et al., 1979) in oropharyngeal 
swabs and blood samples, 
respectively (Fig. 1). Of these, only 
one Daubenton’s bat (0.4%) was 
found positive for EBLV-2b RNA in 
RT-PCR using nested primers 
(Vazquez-Moron et al., 2006). Since 
virus isolation over four passages 
using RTCIT was negative, it was 
not considered a reportable case 
(Picard et al., 2005). This bat was 
an adult female caught in Genthod 
in the canton of Geneva not 
showing any signs of poor health 
condition or bizarre behaviour.  
Phylogenetic reconstruction 
revealed close relatedness of the 
sequence of this sample with the 
other three EBLV-2b sequences 
previously identified in Swiss 
Daubenton’s bats, particularly to the 
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one that has been found in Geneva 
city in 2002. The bootstrap support 
for the subdivision of EBLV-2 in the 
lineages EBLV-2a and EBLV-2b as 
suggested before (Amengual et al. 
1997) was reasonable (not shown). 
Furthermore, 202 blood samples of 
the captured bats (124 M. 
daubentoni, 48 M. myotis, 17 E. 
serotinus and 14 N. noctula) were 
tested individually for rabies virus 
neutralising antibodies using CVS 
and/or EBLV-2b as challenge virus. 
Three Daubenton’s bats from 
different sampling sites were found 
to be seropositive. The positive 
samples were from Baulmes, canton 
of Vaud, Dorigny, canton of Vaud 
and Genthod, canton of Geneva. 
The detection of neutralizing 
antibodies in blood samples, 
indicating past exposure to EBLV, 
and the detection of viral RNA in 
oropharyngeal swabs suggest recent 
active circulation of EBLV in Swiss 
Daubenton’s bats. No positive 
sample either in serology or RT-PCR 
was found in the other three species 
sampled (Serotine bat, Noctule bat 
and Greater Mouse-eared bat). The 
seroprevalence in Daubenton’s bat 
was 2.4% (3/124 bats tested), 
whereas the prevalence estimated 
by RT-PCR was 0.7% (1/148 bats). 
This low prevalence seems to be in 
accordance with the north-to-south 
gradient in the frequency of EBLVs 
Figure 1: The distribution of records from the targeted bat rabies 
surveillance in Switzerland 2009. Sampling sites are indicated with 
coordinates of individual samples shifted for clarity. Only samples 
tested in both RT-PCR in saliva and in neutralization test are included. 
Bat species and samples with positive results are indicated. 
 7 
detected in Western Europe (Müller, 
1996). The present work confirms 
EBLV-2 infection in Daubenton’s 
bats in Switzerland but considering 
the biased sampling, the epidemic 
picture of EBLV remains incomplete. 
Therefore, both active and passive 
surveillance must be maintained in 
order to assess more appropriately 
the potential risk for public health.  
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